Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
Assessing comprehensive score for financial toxicity (COST) among radiation oncology patients in India
Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer
Highlights from AORTIC Cancer Genomics Conference 2021
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions
Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy
Cancer Genomics in Africa today
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021
Managing the treatment of NSCLC patients during the COVID-19 pandemic (IT)
Managing the treatment of NSCLC patients during the COVID-19 pandemic (ES)
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC
Current treatment standards for primary ovarian cancer